- Conditions: Parkinson's Disease; Primary Parkinsonism; Lewy Body Parkinson's Disease
Intervention: Drug: 18F-AV-133
Sponsors: Avid Radiopharmaceuticals; Avid Radiopharmaceuticals
Recruiting - verified May 2012 - Condition: Advanced Parkinson's Disease
Interventions: Drug: Rotigotine; Drug: Placebo
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Parkinson's Disease
Interventions: Drug: Pioglitazone; Drug: placebo
Sponsors: University of Rochester; University of Rochester; National Institute of Neurological Disorders and Stroke (NINDS); Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified October 2011 - Conditions: Parkinson Disease; Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease
Interventions: Drug: preladenant; Drug: Placebo to preladenant
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Parkinson Disease; Idiopathic Parkinson Disease
Interventions: Drug: Preladenant; Drug: Rasagiline; Drug: Placebo to preladenant; Drug: Placebo to rasagiline
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Orthostatic Hypotension; Parkinson's Disease
Intervention: Drug: Droxidopa
Sponsors: Chelsea Therapeutics; Chelsea Therapeutics
Recruiting - verified March 2012 - Condition: Parkinson's Disease Psychosis
Interventions: Drug: pimavanserin tartrate; Drug: placebo
Sponsors: ACADIA Pharmaceuticals Inc.; ACADIA Pharmaceuticals Inc.
Recruiting - verified January 2012 - Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet; Drug: Preladenant 5 mg tablet; Drug: Preladenant 10 mg tablet; Drug: Placebo for Preladenant; Drug: Rasagiline 1 mg capsule; Drug: Placebo for Rasagiline 1 mg capsule
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet; Drug: Preladenant 5 mg tablet; Drug: Preladenant 10 mg tablet; Drug: Rasagiline 1 mg capsule; Drug: Placebo for Rasagiline 1 mg capsule; Drug: Placebo for Preladenant
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Parkinson Disease
Intervention:
Sponsors: Michael J. Fox Foundation for Parkinson's Research; Michael J. Fox Foundation for Parkinson's Research; Institute for Neurodegenerative Disorders
Recruiting - verified July 2011 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Teva Neuroscience, Inc.; H. Lundbeck A/S
Recruiting - verified February 2012 - Conditions: Spinal Cord Stimulation; Deep Brain Stimulation; Drug Infusion (Implantable Pumps); Sacral Nerve Stimulation
Intervention: Device: Various
Sponsors: MedtronicNeuro; MedtronicNeuro
Recruiting - verified December 2011 - Condition: Parkinson's Disease Psychosis
Intervention: Drug: pimavanserin tartrate (ACP-103)
Sponsors: ACADIA Pharmaceuticals Inc.; ACADIA Pharmaceuticals Inc.
Recruiting - verified January 2012


